DUBLIN--(BUSINESS WIRE)--The "Clot Management Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Amid the COVID-19 crisis and the looming economic recession, the Clot Management Devices market worldwide will grow by a projected US$531.2 Million, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 4.4%. Neurovascular Embolectomy Devices, one of the segments analyzed and sized in this study, is forecast to grow at over 5.7% and reach a market size of US$423.1 Million by the end of the analysis period.
The global analysis and forecast periods covered within the report are 2020-2027 (Current & Future Analysis) and 2012-2019 (Historic Review). Research estimates are provided for 2020, while research projections cover the period 2021-2027.
An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Neurovascular Embolectomy Devices market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.
As part of the new emerging geographic scenario, the United States is forecast to readjust to a 5.3% CAGR. Within Europe, Germany will add over US$28.1 Million to the region's size over the next 7 to 8 years. In addition, over US$23 Million worth of projected demand in the region will come from Rest of European markets. In Japan, the Neurovascular Embolectomy Devices segment will reach a market size of US$44.6 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Clot Management Devices market.
Against this backdrop and the changing geopolitical, business and consumer sentiments, the world's second largest economy will grow at 4.3% over the next couple of years and add approximately US$84.5 Million in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Clot Management Devices market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.
Competitors identified in this market include, among others,
- Boston Scientific Corporation
- Cook Medical LLC
- DePuy Synthes
- Edwards Lifesciences Corporation
- iVascular S.L.U
- LeMaitre Vascular, Inc.
- Medtronic PLC
- Straub Medical AG
- Teleflex Inc.
Vascular Solutions, Inc.
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Global Competitor Market Shares
- Clot Management Devices Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Total Companies Profiled: 43
For more information about this report visit https://www.researchandmarkets.com/r/hzyw3b